{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:47:29Z","timestamp":1793771249351,"version":"4.6.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/01.aog.0000289577.32274.a5","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:38:54Z","timestamp":1291102734000},"page":"1304-1310","source":"Crossref","is-referenced-by-count":83,"title":["Mifepristone in Second-Trimester Medical Abortion"],"prefix":"10.1097","volume":"110","author":[{"given":"Nathalie","family":"Kapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Borgatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Stubblefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Vragovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilda","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210201","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-2005-864036","article-title":"Mifepristone in abortion care.","volume":"23","author":"Schreiber","year":"2005","journal-title":"Semin Reprod Med"},{"key":"R3-16-20210201","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2006.03.005","article-title":"The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.","volume":"74","author":"Tang","year":"2006","journal-title":"Contraception"},{"key":"R4-16-20210201","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/9.suppl_1.121","article-title":"The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.","volume":"9","author":"Bygdeman","year":"1994","journal-title":"Hum Reprod"},{"key":"R5-16-20210201","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(85)90115-5","article-title":"Progesterone receptor blockage: effect on uterine contractility and early pregnancy.","volume":"32","author":"Bygdeman","year":"1985","journal-title":"Contraception"},{"key":"R6-16-20210201","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199408043310502","article-title":"A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.","volume":"331","author":"Jain","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-16-20210201","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1520-6661(199805\/06)7:3<115::AID-MFM3>3.0.CO;2-N","article-title":"Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.","volume":"7","author":"Dickinson","year":"1998","journal-title":"J Matern Fetal Med"},{"key":"R8-16-20210201","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.contraception.2005.04.016","article-title":"A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion.","volume":"72","author":"Borgatta","year":"2005","journal-title":"Contraception"},{"key":"R9-16-20210201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.contraception.2006.03.018","article-title":"Review of medical abortion using mifepristone in combination with a prostaglandin analogue.","volume":"74","author":"Fiala","year":"2006","journal-title":"Contraception"},{"key":"R10-16-20210201","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM200101043440107","article-title":"Misoprostol and pregnancy.","volume":"344","author":"Goldberg","year":"2001","journal-title":"N Engl J Med"},{"key":"R11-16-20210201","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1471-0528.2005.00727.x","article-title":"A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.","volume":"112","author":"Herabutya","year":"2005","journal-title":"BJOG"},{"key":"R12-16-20210201","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mob.2002.127461","article-title":"A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination.","volume":"187","author":"Bebbington","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R13-16-20210201","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/dei204","article-title":"Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"R14-16-20210201","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.contraception.2005.12.004","article-title":"Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.","volume":"73","author":"Goh","year":"2006","journal-title":"Contraception"},{"key":"R15-16-20210201","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.","volume":"332","author":"El-Refaey","year":"1995","journal-title":"N Engl J Med"},{"key":"R16-16-20210201","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-0528.1990.tb01714.x","article-title":"Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.","volume":"97","author":"Rodger","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"R17-16-20210201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","article-title":"Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases.","volume":"69","author":"Ashok","year":"2004","journal-title":"Contraception"},{"key":"R18-16-20210201","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1479-828X.2006.00646.x","article-title":"Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.","volume":"46","author":"Rose","year":"2006","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R19-16-20210201","first-page":"301","article-title":"Outpatient abortion for fetal anomaly and fetal death from 15-34 menstrual weeks\u2019 gestation: techniques and clinical management.","volume":"81","author":"Hern","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R20-16-20210201","first-page":"543","article-title":"Mifepristone for preinduction cervical ripening beyond 41 weeks\u2019 gestation: a randomized controlled trial.","volume":"96","author":"Wing","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R21-16-20210201","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/00220345980770031201","article-title":"Software support for clinical studies: review of nQuery advisor release 2.0.","volume":"77","author":"Hodges","year":"1998","journal-title":"J Dent Res"},{"key":"R22-16-20210201","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2007.06.010","article-title":"Intervention rates for placental removal following induction abortion with misoprostol.","volume":"76","author":"Green","year":"2007","journal-title":"Contraception"},{"key":"R23-16-20210201","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R24-16-20210201","article-title":"Analysis of survival data.","author":"Cox","year":"1984"},{"key":"R25-16-20210201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2006.12.013","article-title":"Intravaginal gemeprost and second-trimester pregnancy termination in the scarred uterus.","volume":"97","author":"Marinoni","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"R26-16-20210201","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.contraception.2005.09.007","article-title":"Termination of pregnancy in patients with previous cesarean section.","volume":"73","author":"Mazouni","year":"2006","journal-title":"Contraception"},{"key":"R27-16-20210201","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.contraception.2006.03.023","article-title":"The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.","volume":"74","author":"Daponte","year":"2006","journal-title":"Contraception"},{"key":"R28-16-20210201","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response.","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R29-16-20210201","first-page":"1294","article-title":"A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality.","volume":"101","author":"Dickinson","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R30-16-20210201","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mob.2002.121085","article-title":"The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination.","volume":"186","author":"Dickinson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R31-16-20210201","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000088048","article-title":"Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.","volume":"20","author":"Guix","year":"2005","journal-title":"Fetal Diagn Ther"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200712000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:57Z","timestamp":1786041957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200712000-00016"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aog.0000289577.32274.a5","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}